Quantification of polyoma BK viruria in hemorrhagic cystitis complicating bone marrow transplantation

Blood

Volumn 98, Issue 6, 2001, Pages 1971-1978

  Leung, Anskar Y H ^a   Suen, Christine K M ^a   Lie, Albert K W ^a   Liang, Raymond H S ^a   Yuen, Kwok Y ^a   Kwong, Yok L ^a  

^a QUEEN MARY HOSPITAL   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS; ADOLESCENT; ADULT; AGED; ARTICLE; BK VIRUS; BONE MARROW TRANSPLANTATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GRAFT VERSUS HOST REACTION; HEMATURIA; HEMORRHAGIC CYSTITIS; HUMAN; LOGISTIC REGRESSION ANALYSIS; MALE; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RISK FACTOR; UROTHELIUM; VIREMIA; VIRUS REACTIVATION;

EID: 0035885944     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V98.6.1971     Document Type: Article

References (32)

1. Sencer SF, Haake RJ, Weisdorf DJ. Hemorrhagic cystitis after bone marrow transplantation. Transplantation. 1993;56:875-879.
2. Santos GW, Tutchka PJ, Brookmeyer R, et al. Marrow transplantation for acute non-lymphocytic leukemia after treatment with busulfan and cyclophosphamide. N Engl J Med. 1983;309:1347-1353.
3. Brugieres L, Hartmann O, Travagli JP, et al. Hemorrhagic cystitis following high-dose chemotherapy and bone marrow transplantation in children with malignancies: incidence, clinical course, and outcome. J Clin Oncol. 1989;7:194-199.
4. Bedi A, Miller CB, Hanson JL, et al. Association of BK virus with failure of prophylaxis against hemorrhagic cystitis following bone marrow transplantation. J Clin Oncol. 1995;13:1103-1109.
5. Yang CC, Hurd DD, Douglas Case L, Assimos DG. Hemorrhagic cystitis in bone marrow transplantation. Urology. 1994;44:322-328.
6. Philips FS, Sternberg SS, Cronin AP, et al. Cyclophosphamide and urinary bladder toxicity. Cancer Res. 1961;21:1577-1589.
7. Shepherd JD, Pringle LE, Barnett MJ, et al. Mesna versus hyperhydration for the prevention of cyclophosphamide-induced hemorrhagic cystitis in bone marrow transplantation. J Clin Oncol. 1991;9:2016-2020.
8. Thomas AE, Patterson J, Prentice HG, et al. Haemorrhagic cystitis in bone marrow transplantation patients: possible increased risk associated with prior busulfan therapy. Bone Marrow Transplant. 1987;1:347-355.
9. Nevo S, Swan V, Enger C, et al. Acute bleeding after bone marrow transplantation (BMT) - incidence and effect on survival. Blood. 1998;91:1469-1477.
10. Ringden O, Labopin M, Tura S, et al. A comparison of busulfan versus total body irradiation combined with cyclophosphamide as conditioning for autograft or allograft bone marrow transplantation in patients with acute leukaemia. Acute Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT). Br J Haematol. 1996;93:637-645.
11. Öst L, Lönnqvist B, Eriksson L, et al. Hemorrhagic cystitisa manifestation of graft-versus-host disease? Bone Marrow Transplant. 1987;2:19-25.
12. Arthur RR, Shah KV, Baust SJ, et al. Association of BK viruria with hemorrhagic cystitis in recipients of bone marrow transplants. N Engl J Med. 1986;315:230-234.
13. Arthur RR, Shah KV, Charache P, Saral R. BK and JC virus infections in recipients of bone marrow transplants. J Infect Dis. 1988;158:563-569.
14. Apperley JF, Rice SJ, Bishop JA, et al. Late-onset hemorrhagic cystitis associated with urinary excretion of polyomaviruses after bone marrow transplantation. Transplantation. 1987;43:108-112.
15. Cottler-Fox M, Lynch M, Deeg HJ, Koss LG. Human polyomavirus: lack of relationship of viruria to prolonged or severe hemorrhagic cystitis after bone marrow transplant. Bone Marrow Transplant. 1989;4:279-282.
16. Bogdanovic G, Ljungman P, Wand F, Dalianis T. Presence of human polyomavirus DNA in the peripheral circulation of bone marrow transplant patients with and without hemorrhagic cystitis. Bone Marrow Transplant. 1996;17:573-576.
17. Azzi A, Cesaro S, Laszlo D, et al. Human polyomavirus BK (BKV) load and haemorrhagic cystitis in bone marrow transplantation patients. J Clin Virol. 1999;14:79-86.
18. Chan PKS, Ip KWY, Shiu SYW, et al. Association between polyoma viruria and microscopic haematuria in bone marrow transplantation recipients. J Infect. 1994;29:139-146.
19. Imperiale MJ. The human polyomaviruses, BKV and JCV: molecular pathogenesis of acute disease and potential role in cancer. Virology. 2000;267:1-7.
20. Dörries K. New aspects in the pathogenesis of polyomavirus-induced disease. Adv Virus Res. 1997;48:205-261.
21. Orlando C, Pinzani P, Pazzagli M. Developments in quantitative PCR. Clin Chem Lab Med. 1998;36:255-269.
22. Azzi A, Cesaro S, Laszlo D, et al. Human polyomavirus BK (BKV) load and haemorrhagic cystitis in bone marrow transplantation patients. J Clin Virol. 1999;14:79-86.
23. Hogan TF, Borden EC, McBain JA, Padgett BL, Walker DL. Human polyomavirus infections with JC virus and BK virus in renal transplant patients. Ann Intern Med. 1980;92:373-378.
24. Nickeleit V, Hirsch HH, Binet IF, et al. Polyomavirus infection of renal allograft recipients: from latent infection to manifest disease. J Am Soc Nephrol. 1999;10:1080-1089.
25. Dörries K. Human polyomaviruses. In: Zuckerman AJ, Banatvala JE, Pattison JR, eds. Principles and Practice of Clinical Virology. 4th ed. New York, NY: John Wiley & Sons. 2000;19:619-643.
26. Grundy JE, Shanley JD, Griffiths PD. Is cytomegalovirus interstitial pneumonitis in transplant recipients an immunopathological condition? Lancet. 1987;31:996-999.
27. Cheng VCC, Yuen KY, Chan WM, et al. Immunorestitution disease involving the innate and adaptive response. Clin Infect Dis. 2000;30:882-892.
28. Childs R, Sanchez C, Engler H, et al. High incidence of adeno- and polyomavirus-induced hemorrhagic cystitis in bone marrow allotransplantation for hematological malignancy following T cell depletion and cyclosporine. Bone Marrow Transplant. 1998;22:889-893.
29. Hale GA, Heslop HE, Krance RA, et al. Adenovirus infection after pediatric bone marrow transplantation. Bone Marrow Transplant. 1999;23:277-282.
30. Nickeleit V, Kumkait T, Binet IF, et al. Testing for polyoma virus type BK DNA in plasma to identify renal-allograft recipients with viral nephropathy, N Engl J Med. 2000;342:1309-1315.
31. Cundy KC. Clinical pharmacokinetics of the antiviral nucleotide analogues cidofovir and adefovir. Clin Pharmacokinet. 1999;36:127-143.
32. Portolani M, Pietrosemoli P, Cermelli C, et al. Suppression of BK virus replication and cytopathic effect by inhibitors of prokaryocytic DNA gyrase. Antiviral Res. 1998;9:205-218.